Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$87.2 - $114.05 $30,345 - $39,689
-348 Reduced 2.39%
14,231 $1.53 Million
Q1 2022

May 12, 2022

SELL
$94.19 - $124.49 $50,391 - $66,602
-535 Reduced 3.54%
14,579 $1.62 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $1.36 Million - $1.58 Million
11,351 Added 301.65%
15,114 $1.94 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $148,471 - $193,596
1,360 Added 56.6%
3,763 $500,000
Q2 2021

Aug 13, 2021

SELL
$100.34 - $115.69 $30,102 - $34,707
-300 Reduced 11.1%
2,403 $259,000
Q1 2021

May 13, 2021

SELL
$101.51 - $125.27 $60,804 - $75,036
-599 Reduced 18.14%
2,703 $284,000
Q4 2020

Feb 10, 2021

SELL
$85.88 - $105.36 $60,116 - $73,752
-700 Reduced 17.49%
3,302 $343,000
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $145 - $185
2 Added 0.05%
4,002 $342,000
Q1 2020

May 11, 2020

BUY
$36.95 - $62.95 $147,800 - $251,800
4,000 New
4,000 $207,000
Q2 2019

Aug 13, 2019

SELL
$39.26 - $54.21 $290,524 - $401,154
-7,400 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$29.84 - $43.92 $1.54 Million - $2.27 Million
-51,705 Reduced 87.48%
7,400 $0
Q4 2018

Feb 11, 2019

BUY
$29.95 - $46.34 $125,161 - $193,654
4,179 Added 7.61%
59,105 $1.84 Million
Q3 2018

Nov 09, 2018

SELL
$40.12 - $45.55 $80 - $91
-2 Reduced -0.0%
54,926 $0
Q2 2018

Aug 09, 2018

SELL
$38.72 - $42.52 $309 - $340
-8 Reduced 0.01%
54,928 $0
Q1 2018

May 11, 2018

BUY
$39.4 - $47.39 $393,684 - $473,520
9,992 Added 22.23%
54,936 $0
Q4 2017

Feb 12, 2018

BUY
$37.27 - $43.02 $41,593 - $48,010
1,116 Added 2.55%
44,944 $0
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $1.48 Million - $1.83 Million
43,828
43,828 $1.75 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.